GENE ONLINE|News &
Opinion
Blog

2025-12-02|

Study Explores Web-Based Tools to Improve Medication Management for Adolescents on Multiple Prescriptions

by GOAI
Share To

A recent study published in the journal *BMC Health Services Research* highlights the potential of web-based technology to improve medication management for adolescents prescribed multiple medications, a practice known as polypharmacy. Researchers conducted the study in response to a growing trend of young individuals requiring complex medication regimens, aiming to explore innovative solutions for improving adherence and reducing associated risks.

The study examined how digital tools can assist teenagers and their caregivers in organizing, tracking, and managing medications effectively. It focused on addressing challenges such as missed doses, incorrect usage, and communication gaps between patients and healthcare providers. The findings suggest that web-based platforms may offer practical benefits by streamlining medication schedules, providing reminders, and facilitating better coordination among stakeholders involved in adolescent care. Researchers emphasized the importance of leveraging technology to meet the unique needs of this demographic as polypharmacy rates continue to rise.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 3, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top